about
A curated and standardized adverse drug event resource to accelerate drug safety researchValidating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortalityKnowledge retrieval from PubMed abstracts and electronic medical records with the Multiple Sclerosis OntologyProton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General PopulationMining Electronic Health Records using Linked DataComputational approaches for pharmacovigilance signal detection: toward integrated and semantically-enriched frameworksBig data in medicine is driving big changesBig data - smart health strategies. Findings from the yearbook 2014 special themeDose-Specific Adverse Drug Reaction Identification in Electronic Patient Records: Temporal Data Mining in an Inpatient Psychiatric PopulationToward enhanced pharmacovigilance using patient-generated data on the internetFunctional evaluation of out-of-the-box text-mining tools for data-mining tasks.A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions.Medication-wide association studies.Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events.Profiling risk factors for chronic uveitis in juvenile idiopathic arthritis: a new model for EHR-based research.Ongoing challenges in pharmacovigilance.Toward personalizing treatment for depression: predicting diagnosis and severity.Text mining for adverse drug events: the promise, challenges, and state of the art.Androgen Deprivation Therapy and Future Alzheimer's Disease RiskA time-indexed reference standard of adverse drug reactions.Pharmacovigilance in oncology: evaluation of current practice and future perspectives.Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma.An empirically derived taxonomy of errors in SNOMED CT.A formal concept analysis and semantic query expansion cooperation to refine health outcomes of interestLeveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.Predictive modeling of structured electronic health records for adverse drug event detection.Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review.Feasibility of Prioritizing Drug-Drug-Event Associations Found in Electronic Health Records.DISCOVERING PATIENT PHENOTYPES USING GENERALIZED LOW RANK MODELSA method for systematic discovery of adverse drug events from clinical notesPredictive modeling of risk factors and complications of cataract surgeryThe digital revolution in phenotyping.Identifying phenotypic signatures of neuropsychiatric disorders from electronic medical records.Automated extraction of clinical traits of multiple sclerosis in electronic medical records.Mining clinical text for signals of adverse drug-drug interactions.Cross-domain targeted ontology subsets for annotation: the case of SNOMED CORE and RxNormIntegrative approaches for predicting in vivo effects of chemicals from their structural descriptors and the results of short-term biological assays.Using the wisdom of the crowds to find critical errors in biomedical ontologies: a study of SNOMED CT.Creation and Validation of an EMR-based Algorithm for Identifying Major Adverse Cardiac Events while on StatinsDiscovering associations between adverse drug events using pattern structures and ontologies.
P2860
Q24658583-59742F15-55AB-46C5-99EF-930687563A92Q24745996-33809291-4A57-42B7-8741-D0D5207048C5Q28543366-DFA01501-6F0D-49AB-9EBD-18672413D41FQ28548045-7CFFD7BC-AE9D-4B7F-9A68-117B077E318EQ28645606-A316EF1C-1C6A-4496-A0CB-6F927E0B7876Q28651547-EF56FEB3-6956-49C0-A488-32AD84627A01Q28652529-046DEDE4-DED4-4777-8F77-15FC79076B70Q28652537-CF2988CC-48D3-4EA5-853F-BEB3BB0A26EBQ30002404-3191C433-3649-4271-A6C3-FB730EBE6398Q30796597-B8F87667-1D26-4C58-A185-4658E0782569Q30863601-6D590349-F477-40F6-BB93-FB11B0B748EAQ30979182-19A3B2D1-2AE4-4E59-91A6-B3266DD55D8DQ33633627-F08F071F-3EE7-436B-A392-FFB1170500E6Q34154208-92B1FF3B-1F5A-40C2-BFCE-A282689F08A3Q34248642-82782FC7-2159-4DEF-B22B-A1882F73FDFDQ34417013-1CD5F1D0-31B7-46B5-A5DF-13F491284ED3Q34430123-B6043AE7-D840-4DB3-90D7-39F93366E439Q34442663-3BA610FE-1A3E-4F77-846F-07151F320E64Q34504328-70806423-8BB1-4F6B-90EA-4C7FC57128E4Q35012194-1CE70B7B-AEDD-41F5-B415-9290580014D2Q35183601-DCE6E00E-E865-4AFF-97FA-8AA56FA6E162Q35345665-B9066BC5-72D7-4EF8-B8C4-236966084EF3Q35570341-6B995136-99B9-4DB0-AAD7-F52B9CE6CBE9Q35653125-C559B5F3-ECE6-43C7-B7FF-DF39DFCD860EQ35765427-EF373777-E61C-45FE-8812-3390A7B34C7FQ35852286-C8D92BC7-5DDB-497D-BD9B-A84916E96CA5Q36413039-02F6BAFC-3250-4A8D-9911-9ADE161DF8EAQ36460556-D2C0392C-73D4-42FB-8E0B-0970894914F9Q36813373-D1649826-0C6F-4379-B835-5611838453AEQ37040215-2B3C230A-8E0B-491D-8C21-CF73969A128EQ37060215-F5F092F1-85AF-455E-81F5-BF96B0654DD9Q37284033-5D160711-E8B8-4865-902F-C2A56A7041A3Q37389419-13E28EE3-0E76-4F1C-BD74-BFC7AA7F7C4BQ37389444-4DB9908B-F8BA-4C05-AD4F-57F5977C00C0Q37598930-16443ACD-1452-4545-BB85-CAAE232CC636Q37633341-18143862-4A80-4EF0-A4EB-A50702966FA5Q38209986-1670B646-8166-4118-ACB0-C632D1244783Q38262429-E7B9E136-25A7-4F3B-857D-9CC7F341A5FEQ38365384-C2BFCE87-3E19-458C-BE9D-D697A31ADD1BQ38371804-DB19AC21-C4FB-41F7-9793-6D10FF6AA5D1
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmacovigilance Using Clinical Notes
@ast
Pharmacovigilance Using Clinical Notes
@en
type
label
Pharmacovigilance Using Clinical Notes
@ast
Pharmacovigilance Using Clinical Notes
@en
prefLabel
Pharmacovigilance Using Clinical Notes
@ast
Pharmacovigilance Using Clinical Notes
@en
P2093
P2860
P3181
P356
P1476
Pharmacovigilance Using Clinical Notes
@en
P2093
A Bauer-Mehren
J M Mortensen
T A Ferris
T Podchiyska
P2860
P304
P3181
P356
10.1038/CLPT.2013.47
P407
P577
2013-03-04T00:00:00Z